A new research suggests that fenofibrate - a common drug used to control cholesterol levels in patients - activates the same receptors as cannabis and may become a viable treatment option for relieving pain, stimulating appetite, reducing nausea and preventing depression."By illustrating the relationship between fenofibrate and the cannabinoid system, we aim to improve our understanding of this clinically important drug," said researcher Richard S. Priestley from the University of Nottingham, England.

According to the research report published in the FASEB Journal, fenofibrate may benefit a wide range of health issues, such as appetite stimulation, pain and nausea control, as well as immune and various psychiatric and neurological conditions.This suggests that fenofibrate may be the starting point for a new class of cannabis-like drugs to treat these types of conditions."Our study provides the basis for the investigation of new drugs targeting these important receptors," Priestley said.To make this discovery, Priestly and colleagues cultured cells containing cannabinoid receptors and exposed them to a tracer compound, which binds to cannabinoid receptors.

Latest News from Lifestyle News Desk